10953 δ radd strains (ATCC)
Structured Review

10953 δ Radd Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 904 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/10953 δ radd strains/product/ATCC
Average 97 stars, based on 904 article reviews
Images
1) Product Images from "RadD from Fusobacterium nucleatum Engages NKp46 to Promote Antitumor Cytotoxicity"
Article Title: RadD from Fusobacterium nucleatum Engages NKp46 to Promote Antitumor Cytotoxicity
Journal: bioRxiv
doi: 10.1101/2025.07.26.666929
Figure Legend Snippet: The figure shows histograms of FITC-labeled F. nucleatum subsp. nucleatum ATCC 23726 (FN23726) (upper histograms) and ATCC 10953 (lower histograms) incubated with 2 μg of NKp46 Ig, D1 domain of NKp46 (D1 Ig), Ncr-1 Ig, and CD16 Ig fusion proteins. Representative staining from one of two independent experiments is shown.
Techniques Used: Labeling, Incubation, Staining
Figure Legend Snippet: A-B. Density plot of FITC labeled ATCC 10953 (A) and its ΔfadI mutant derivative ATCC 10953 ΔFad-I (B) stained with the various fusion proteins (listed in the X axis). C. Schematic representation of ATCC 10953 wild type (WT) strain and RadD surface expression (Left) compared to ATCC 10953 ΔFad-I (Right). D. Density plot of the FITC-labeled ΔRadD mutant strain of ATCC 10953 stained with various fusion proteins (listed in the X axis). The figure shows data from one representative experiment out of three to five independent experiments. E. Fold change quantification of FITC-labeled bacteria binding to the fusion proteins Ccm1-Ig, NKp46 Ig and Ncr-1 Ig in ATCC 10953 (left) and ATCC 23726 (right). Summary of three to five independent experiments. The mean value ±SD of the experiments is presented. * P < 0.05, ** P ≤ 0.01, *** P ≤ 0.001 and **** P ≤ 0.0001.
Techniques Used: Labeling, Mutagenesis, Staining, Expressing, Bacteria, Binding Assay
Figure Legend Snippet: A. Quantification of Median Fluorescent Intensity (MFI) of FITC-labeled ATCC 10953 binding to Ccm1-Ig, NKp46-Ig, and Ncr-1 Ig, without or with 5 and 10 mM of L-Arginine. Data combined from three to four independent experiments are presented. B. NKp46-Ig (2 µg) was pre-incubated with 1 µg of a control anti-PVR antibody and NKp46 monoclonal antibodies (9E2, 461-G1, and 02) to evaluate the blocking of ATCC 10953 interaction with the NKp46 receptor. C. Shows the quantification results of histograms depicted in A. The mean value ±SD of the experiments is presented. * P < 0.05, ** P ≤ 0.01, *** P ≤ 0.001 and **** P ≤ 0.0001.
Techniques Used: Labeling, Binding Assay, Incubation, Control, Bioprocessing, Blocking Assay
Figure Legend Snippet: A. Schematic diagram showing the design of the NK cells cytotoxicity assay against breast cancer cell lines T47D and MCF7. 1. Tumor cells were stained with Calcein-AM dye and then incubated either with tumor cells (T47D or MCF7) only, tumor + NK, tumor + bacteria ( ATCC 10953 WT and ATCC 10953 ΔRadD ) + NK with/without preincubation with 02 antibody. 2. Killing assays were performed in a 37°C incubator for 4 hours. 3. The fluorescence intensity of Calcein was measured to determine cell viability using a spectrophotometer (Tecan Spark). Summary of NK cytotoxicity against T47D (B) and MCF7 (C) breast cancer cell lines. Combined results from five independent experiments. D. C57BL\6 or NCR1-KO mice were shaved and AT3 cells (1 x 10 ^6 cells in 100 μl PBS) were injected one day later into the mammary fat pad. When tumors reached a size of about 500 mm 3 , mice were inoculated intravenously with 5 × 10 7 ATCC 10953 WT and 7.5 × 10 7 ATCC 10953 Δ RadD bacteria. Eight days later, mice were sacrificed and tumor weight was determined. E. The tumor weight of C57BL or NCR1-KO (F) mice. The figure shows the combination of 4-5 experiments performed. The mean value ±SD of the experiments is presented. * P < 0.05, ** P ≤ 0.01, *** P ≤ 0.001 and **** P ≤ 0.0001.
Techniques Used: Cytotoxicity Assay, Staining, Incubation, Bacteria, Fluorescence, Spectrophotometry, Injection



